MiddleBrook launches first Pulsys formulation, Moxatag
This article was originally published in Scrip
Executive Summary
MiddleBrook Pharmaceuticals has launched Moxatag, the first once-daily amoxicillin tablet to be marketed in the US, more than a year after it was approved by the FDA.